GovChime

6505-01-523-0353 Zolmitriptan tablet

One item DLA buys: its open requests for quotation, approved sources and past DLA awards.

Overview

National Stock Number record

Open RFQs
1
Next due November 18, 2026
Last price paid
…
Standard price
$83.20 per PG
DLA's catalog price, not a price paid
Approved sources
2
Awards on record
362
2014 to 2026
DLA demand
–

Identification

Item name
Zolmitriptan tablet
NSG (group)
65 · Medical/dental/veterinary eqpt/supp
NIIN assigned
18-AUG-04
Unit
PG
NSN
6505-01-523-0353
NIIN
01-523-0353

Name, end product, NIIN date and unit: DLA's Federal Logistics Information System (PUB LOG). Source: the request-for-quotation (RFQ) files DLA publishes on DIBBS each day. An RFQ that is also a SAM.gov notice links to that notice. Return-by dates are DIBBS's.

Approved suppliers

Manufacturers and part numbers DLA has qualified for this item, and the part numbers in its catalog record

SupplierCAGECAGE statusPart status (RNCC / RNVC)Supplier part #Listed in
JUBILANT CADISTA PHARMACEUTICALS INC.441M0A (Active)3 (Design control reference) / 2 (An item-identifying number)NDC59746-0461-16DLA approved-source file
AVKARE LLC4QGW8A (Active)5 (Secondary reference) / 2 (An item-identifying number)NDC42291-0998-06DLA approved-source file
Impax Laboratories, LLCWon before1C6A0H (Obsolete entity has been discontinued)5 (Secondary reference) / 9 (Was the design control reference)ZOMIG ZMTFLIS part list
6YA44A (Active)5 (Secondary reference) / 9 (Was the design control reference)NDC68382-0715-86FLIS part list
7A4E3A (Active)5 (Secondary reference) / 9 (Was the design control reference)NDC68462-0499-76FLIS part list
89875A (Active)5 (Secondary reference) / 1 (Not identify an item of production without the use of additional information)04-1171FLIS part list

Source: DLA's approved-source file published with the RFQs and the part list of DLA's catalog record (FLIS). CAGE and part status are FLIS's codes with DLA's wording.

Pricing and awardees

Supply contracts

3 contracts DLA ordered this item under

Award IDAwardeeAwarding officeCeilingOrdering endsTypeMultiple awardOrdersLast order
SPE2DX25D8022CARDINAL HEALTH, INC.SPE2DX$76,117,432March 6, 2035INDEFINITE DELIVERY / REQUIREMENTSNo15September 25, 2026
SPE2DX15D0022CARDINAL HEALTH, INC.SPE2DX$20,000,000June 30, 2025INDEFINITE DELIVERY / INDEFINITE QUANTITYNo22December 11, 2018
SPE2DX15D9383DMS PHARMACEUTICAL GROUP INCSPE2DX$4,999,999December 31, 2025INDEFINITE DELIVERY / INDEFINITE QUANTITYNo8May 28, 2018

Source: DLA's procurement history files (the contract each order was placed under), the item's newest 2,000 award lines, joined to FPDS by the contract number. Multiple award, ordering period and ceiling are FPDS's; DLA's files do not give them.

Characteristics

Government-defined characteristics of this item (FLIS)

Hazardous and environmental

Hazardous material (HMIC)
P (No information in hmirs)

Product characteristics

CodeRequirementDescription
TEXTGeneral characteristics item descriptionAMERICAN HOSPITAL FORMULARY SERVICE CLASSIFICATION NUMBER: 28:92.00
CXCYPart name assigned by controlling agencyZOLMITRIPTAN TABLETS BLISTER PACK 6S
FEATSpecial featuresACTIVE INGREDIENT AND STRENGTH: ZOLMITRIPTAN 2.5 MG; ORALLY RAPIDLY DISINTEGRATING TABLETS; UNIT-DOSE, INDIVIDUALLY SEALED; USED IN TREATMENT OF MIGRAINES; PKG. OF 6

Additional identifiers

II
0
DEMIL
A: No demilitarization required
Precious metals (PMIC)
A (Does not contain precious metal)
PINC
1836721
Criticality (CRIT CD)
X
On FedMall
Yes

Source: DLA's PUB LOG files (FLIS Data Electronic Reading Room), updated monthly; code wording from DLA's code table (P_HELP).

Major organizational entity (MOE) rules

How each service or agency buys and manages this item

RuleMOEAMCAMSCNIMSCIMCAACDSOR
A911Army (DA)3From the actual manufacturer (second or later time)ZCommercial or off-the-shelf item
FSGMAir Force (DF)3From the actual manufacturer (second or later time)ZCommercial or off-the-shelf item
MC55Marine Corps (DM)3From the actual manufacturer (second or later time)ZCommercial or off-the-shelf item
N9BLNavy (DN)3From the actual manufacturer (second or later time)ZCommercial or off-the-shelf item

Source: DLA's PUB LOG files (FLIS Data Electronic Reading Room), updated monthly; code wording from DLA's code table (P_HELP). AMC and AMSC wording: DFARS PGI 217.7506. Hover a code for DLA's wording.

Government organizations

The services and agencies that manage or use this item

OrganizationEffective dateUnit of issueUnit priceQty per unitControlled inventoryShelf lifeAcquisition adviceSource of supply
Army (DA)01-OCT-2025PG$60.391 (1)U (Unclassified)Q (36 months)L (Local purchase)SMS (Defense logistics agency)
Air Force (DF)01-OCT-2025PG$60.391 (1)U (Unclassified)Q (36 months)L (Local purchase)SMS (Defense logistics agency)
Marine Corps (DM)01-OCT-2025PG$60.391 (1)U (Unclassified)Q (36 months)L (Local purchase)SMS (Defense logistics agency)
Navy (DN)01-OCT-2025PG$60.391 (1)U (Unclassified)Q (36 months)L (Local purchase)SMS (Defense logistics agency)
DLA (DS)01-OCT-2026PG$83.201 (1)U (Unclassified)Q (36 months)L (Local purchase)SMS (Defense logistics agency)

Source: DLA's PUB LOG files (FLIS Data Electronic Reading Room), updated monthly; code wording from DLA's code table (P_HELP). Unit prices are DLA's standard prices (its catalog price to its customers, with DLA's surcharge), not prices DLA paid.

Packaging

FLIS packaging data of this item

FLIS packaging

Level A
Z (Special requirement)
Level B
Z (Special requirement)
Unit container
ZZ (Special requirement)

Source: DLA's PUB LOG files (FLIS Data Electronic Reading Room), updated monthly; code wording from DLA's code table (P_HELP).

DIBBS RFQs

Recent DLA requests for quotation for this item on DIBBS, newest first: 1 open now

SolicitationNSNItem nameQtyUnitStd. priceLast priceEst. valueSet-asideTech docsPostedReturn by
SPE2DP27T0293DIBBS only6505-01-523-0353Zolmitriptan tablet6PG$83.20 per PG……No set-asideYesNovember 12, 2026November 18, 20265 days left
SPE2DP27T0163DIBBS only6505-01-523-0353Zolmitriptan tablet3PG$83.20 per PG……No set-asideYesOctober 25, 2026November 2, 2026Closed
SPE2DP27T0101DIBBS only6505-01-523-0353Zolmitriptan tablet3PG$83.20 per PG……No set-asideYesOctober 13, 2026October 19, 2026Closed
SPE2DP26T2699DIBBS only6505-01-523-0353Zolmitriptan tablet3PG$83.20 per PG……No set-asideNovember 3, 2026First seenApril 13, 2026Closed
SPE2DP26T3217DIBBS only6505-01-523-0353Zolmitriptan tablet6PG$83.20 per PG……No set-asideNovember 3, 2026First seenMay 11, 2026Closed
SPE2DP26T3859DIBBS only6505-01-523-0353Zolmitriptan tablet1PG$83.20 per PG……No set-asideNovember 3, 2026First seenJune 29, 2026Closed
SPE2DP26T3981DIBBS only6505-01-523-0353Zolmitriptan tablet1PG$83.20 per PG……No set-asideNovember 3, 2026First seenJuly 13, 2026Closed
SPE2DP26T4105DIBBS only6505-01-523-0353Zolmitriptan tablet6PG$83.20 per PG……No set-asideNovember 3, 2026First seenJuly 20, 2026Closed
SPE2DP26T4552DIBBS only6505-01-523-0353Zolmitriptan tablet6PG$83.20 per PG……No set-asideNovember 3, 2026First seenAugust 12, 2026Closed
SPE2DP26T4602DIBBS only6505-01-523-0353Zolmitriptan tablet2PG$83.20 per PG……No set-asideNovember 3, 2026First seenAugust 17, 2026Closed

→ These RFQs in the DIBBS list

“First seen”: an RFQ from DIBBS's file of all open RFQs, which gives no issue date. Source: the request-for-quotation (RFQ) files DLA publishes on DIBBS each day. An RFQ that is also a SAM.gov notice links to that notice. Return-by dates are DIBBS's.

DLA forecast

DLA's purchase forecast for the next 24 months, and its lead time

DLA's own figures

Lead time
administrative 15 days, production 113 days (128 in all)

Source: DLA's monthly files in its FOIA reading room: the 24-month demand forecast (what DLA expects to buy, not a commitment) and the ALT/PLT file (administrative lead time: requirement to award; production lead time: award to delivery).

DLA award history

362 award lines since 2014, 5 winning CAGEs

WinnerAwardsLast award
00E55Cardinal Health, Inc.216September 25, 2026
1UNB0DMS PHARMACEUTICAL GROUP INC115December 12, 2022
0AG09SZY HOLDINGS, LLC17October 7, 2026
3W8H0MR UNLIMITED, LLC13March 12, 2026
1C6A0Impax Laboratories, LLC1September 17, 2014
YearAwardsWinning CAGEs
2026193
2025313
2024243
2023522
2022511
2021251
2020492
2019181
2018302
2017221

Source: DLA's award history files (its FOIA reading room: every DLA award line since 2013, refreshed monthly), plus the past awards listed in this item's RFQ documents that those files lack. Counts are award lines, not dollars; surplus buys are left out.

DLA awards for this item

25 awards from the item's award history, in FPDS

RankVendorObligated
1DMS PHARMACEUTICAL GROUP INC$128,182
2CARDINAL HEALTH, INC.$58,347
3SZY HOLDINGS, LLC$2,106
4MR UNLIMITED, LLC$1,227
ContractAwardedAwardeeObligated
SPE2D926F7911From the item's award historyAugust 4, 2026CARDINAL HEALTH, INC.$54
SPE2D926F7866From the item's award historyAugust 3, 2026CARDINAL HEALTH, INC.$107
SPE2D926F6659From the item's award historyJune 12, 2026CARDINAL HEALTH, INC.$268
SPE2D926F5790From the item's award historyMay 15, 2026CARDINAL HEALTH, INC.$107
SPE2D926F5559From the item's award historyMay 7, 2026CARDINAL HEALTH, INC.$107
SPE2D926F4436From the item's award historyApril 8, 2026CARDINAL HEALTH, INC.$54
SPE2D926F4311From the item's award historyApril 7, 2026CARDINAL HEALTH, INC.$54
SPE2D926F4058From the item's award historyMarch 27, 2026CARDINAL HEALTH, INC.$107
SPE2DP26P0602From the item's award historyMarch 17, 2026SZY HOLDINGS, LLC$71
SPE2D926F3650From the item's award historyMarch 13, 2026CARDINAL HEALTH, INC.$107

Showing 1 to 10 of 25 results

Source: DLA award notices on SAM.gov for solicitations that included this item (DLA posts them above $25,000), and the contracts of this item's past DLA awards (DLA's award history files and the RFQs' procurement history), joined to FPDS by contract number (an order under a long-term contract by the order and its contract). Amounts are FPDS obligations; DIBBS order totals are not shown. Department of Defense actions appear in FPDS about 90 days after they are signed.

Winning bids